Maximilian Klar

No ORCID on file · 6 papers in corpus · active 2017-2025

Study types

  • article 3
  • other 2

Condition tags

  • endometriosis 2
  • adenomyosis 1
article 2025
FIGO 2023 stage IIIB2 endometrial cancer with pelvic peritoneal metastasis: Assessment of outcomes of adjuvant therapy
·doi:10.1016/j.ygyno.2025.04.541
other 2024
Nationwide assessment of practice variability in the utilization of hysteropexy at laparoscopic apical suspension for uterine prolapse
AJOG global reports ·doi:10.1016/j.xagr.2024.100322

BACKGROUND: Although hysteropexy has been used to preserve the uterus during uterine prolapse surgery for a long time, there is a scarcity of data that describe the nationwide patterns of use of this surgical procedure. OBJECTIVE: This stu…

article 2022
SUBSTANTIAL VARIABILITY IN OVARIAN CONSERVATION AT HYSTERECTOMY FOR ENDOMETRIAL HYPERPLASIA
·doi:10.1016/j.fertnstert.2022.08.670
2020
Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies.
Journal of surgical oncology ·doi:10.1002/jso.25770

Background and objectivesTo examine the association between hospital surgical volume and perioperative mortality of pelvic exenteration performed for gynecologic malignancies.MethodsA population-based retrospective study utilizing the Natio…

other 2020
Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2019.11.004

STUDY OBJECTIVE: The findings of previous studies have been inconsistent as to whether benign hysterectomy via minimally invasive laparoscopic surgery increases the risk of vesicoureteral injury when compared with laparotomy. The objectives…

article 2017
Bipolar vessel-sealing devices in laparoscopic hysterectomies: a multicenter randomized controlled clinical trial
Archives of gynecology and obstetrics ·doi:10.1007/s00404-017-4599-y

ObjectiveTo compare operating time and blood loss in patients undergoing total laparoscopic hysterectomies (TLH) for benign conditions with either the Marseal™ IQ 5 mm (MS) or the Ligasure™ 5 mm (LS) vessel-sealing device.Design and setting…